GST pull-down assays are used to identify protein-protein interactions
In summary, the neuroprotective effects of GLP-1RAs have been demonstrated in various in vivo models of diabetes, aging, AD, and PD
Pro-resolving lipid mediators are leads for resolution physiology
GLP-1 Microdosing refers to the use of lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or liraglutide (Victoza, Saxenda)
This kind of trial is expensive typically several million dollars and to date has been more difficult to justify economically because GHK-Cu cannot be patented as a novel drug (the molecule is endogenous and the relevant patents have expired)
Identification of antidepressant constituents from Xiangfu-chuanxiong herbal medicine pair via spectrum-effect relationship analyses, molecular docking and corticosterone-induced PC12 cells